The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Sanofi
Speakers' Bureau - Amgen; Bayer; Merck; Roche Pharma AG
 
Consulting or Advisory Role - Boehringer Ingelheim (I)
First-line treatment with panitumumab plus FOLFIRI in elderly patients with RAS/BRAF wild-type unresectable metastatic colorectal cancer and good performance status: OPALO trial.
 
Jaime Feliu
No Relationships to Disclose
 
Antonieta Salud
No Relationships to Disclose
 
Estela Pineda Losada
Expert Testimony - Amgen
 
Vicente Alonso
No Relationships to Disclose
 
Antonio Cubillo
No Relationships to Disclose
 
Gemma Soler
No Relationships to Disclose
 
Alberto Carmona
No Relationships to Disclose
 
Ana Ruíz Casado
No Relationships to Disclose
 
Brenzo Martinez-Amores
No Relationships to Disclose
 
Monica Guillot Morales
No Relationships to Disclose
 
Cristina Llorca
No Relationships to Disclose
 
Carmen Castañon Lopez
No Relationships to Disclose
 
Gemma Soler Gonzalez
No Relationships to Disclose
 
Pilar Escudero
No Relationships to Disclose
 
Ismael Macias Declara
No Relationships to Disclose
 
Jorge Aparicio
Consulting or Advisory Role - Amgen; Bayer; Merck; SERVIER; Sirtex Medical